Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Akorn Inc (AKRX) NASDAQ

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview as of [[ item.timeDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 2,532,370
  • Shares Outstanding, K 126,030
  • Annual Sales, $ 985,080 K
  • Annual Income, $ 150,800 K
  • 36-Month Beta 1.12
  • Price/Sales 2.57
  • Price/Book 3.15

Price Performance

See More
Period Period Low Period High Performance
1-Month
17.61 +3.63%
on 12/07/16
23.42 -22.08%
on 11/15/16
-2.01 (-9.92%)
since 11/07/16
3-Month
17.61 +3.63%
on 12/07/16
29.30 -37.71%
on 09/23/16
-8.44 (-31.62%)
since 09/07/16
52-Week
17.57 +3.87%
on 03/18/16
39.46 -53.75%
on 01/06/16
-17.24 (-48.58%)
since 12/07/15

Most Recent Stories

More News
Research Reports Initiation on Healthcare Stocks -- Valeant Pharma, Akorn, Universal Health Services, and LifePoint Health

In today's pre-market research, Stock-Callers.com directs investors' attention to the following Healthcare stocks: Valeant Pharmaceuticals International Inc. (NYSE: VRX), Akorn Inc. (NASDAQ: AKRX), Universal...

Akorn Launches Ibuprofen Oral Suspension

Akorn, Inc. (Nasdaq:AKRX), a leading specialty pharmaceutical company, today announced that it has launched the prescription version of Ibuprofen 100mg/5mL oral suspension in 118mL and 473mL bottles as...

Akorn Invalidates Durezol(R) Patent Via Inter Partes Review Proceeding

Akorn, Inc. (Nasdaq:AKRX), a leading specialty pharmaceutical company, today announced that on November 22, 2016, the Patent Trial and Appeal Board (PTAB) ruled in favor of Akorn in its inter partes review...

Is Mallinckrodt (MNK) Poised for a Beat in Q4 Earnings?

Mallinckrodt plc (MNK) is set to report fourth-quarter fiscal 2016 results on Nov 29. The company has beaten estimates in each of the last four quarters, with a positive average earnings surprise of 11.9%....

Akorn Down 26.4% Since SmarTrend Downtrend Call (AKRX)

SmarTrend identified a Downtrend for Akorn (NASDAQ:AKRX) on August 16th, 2016 at $30.13. In approximately 3 months, Akorn has returned 26.37% as of today's recent price of $22.18.

Downgrade Alert for Akorn (AKRX)

Akorn (NASDAQ:AKRX) was downgraded from Buy to Underperform at BofA/Merrill today. The stock closed yesterday at $20.26 on volume of 3.5 million shares, above average daily volume of 1.5 million. There...

Upgrade Alert for Akorn (AKRX)

Akorn (NASDAQ:AKRX) was upgraded from Hold to Buy at Deutsche Bank today. The stock closed yesterday at $20.26 on volume of 3.5 million shares, above average daily volume of 1.5 million. Akorn, Inc....

Downgrade Alert for Akorn (AKRX)

Akorn (NASDAQ:AKRX) was downgraded from Buy to Hold at WallachBeth today. The stock closed yesterday at $20.26 on volume of 3.5 million shares, above average daily volume of 1.5 million. Akorn, Inc....

Watch for Akorn to Potentially Rebound After Falling 2.71% Yesterday

Akorn (NASDAQ:AKRX) traded in a range yesterday that spanned from a low of $19.28 to a high of $21.08. Yesterday, the shares fell 2.7%, which took the trading range below the 3-day low of $19.90 on volume...

Akorn Shares Down 34.9% Since SmarTrend's Sell Call (AKRX)

SmarTrend identified a Downtrend for Akorn (NASDAQ:AKRX) on August 16th, 2016 at $30.13. In approximately 3 months, Akorn has returned 34.95% as of today's recent price of $19.60.

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More

Business Summary

Akorn, Inc. manufactures and markets diagnostic and therapeutic pharmaceuticals in specialty areas such as ophthalmology, rheumatology, anesthesia and antidotes, among others. They also market ophthalmic surgical instruments and related products. Customers include physicians, optometrists, wholesalers,...

See More

Support & Resistance

2nd Resistance Point 20.70
1st Resistance Point 19.82
Last Price 18.28
1st Support Level 18.42
2nd Support Level 17.90

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.